Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 3.19 is 50% below its 5-year average of 6.36, near the low end of its 5-year range (2.77–13.62).
As of the fiscal period ended Tuesday, June 30, 2026. 2.23% above its 12-month average of 3.12.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 3.19.
CURRENT RATIO
3.19
CURRENT RATIO AVG TTM
3.12
CURRENT RATIO AVG 3Y
3.84
CURRENT RATIO AVG 5Y
6.36
CURRENT RATIO AVG 10Y
7.80
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+2.23%
CURRENT VS 3Y AVG
-17.08%
CURRENT VS 5Y AVG
-49.87%
CURRENT VS 10Y AVG
-59.17%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.59
median of 793 covered companies
CURRENT VS SECTOR MEDIAN
-11.24%
vs the sector median at left
Market Cap
$437.61M
Current Ratio
13.99
TTM Avg
3.82
3Y Avg
4.25
5Y Avg
5.96
Market Cap
$440.53M
Current Ratio
7.35
TTM Avg
8.39
3Y Avg
5.06
5Y Avg
6.73
Market Cap
$447.00M
Current Ratio
12.39
TTM Avg
8.12
3Y Avg
11.14
5Y Avg
10.14
Market Cap
$422.13M
Current Ratio
3.48
TTM Avg
10.77
3Y Avg
42.35
5Y Avg
30.00
Market Cap
$448.85M
Current Ratio
6.72
TTM Avg
10.04
3Y Avg
13.74
5Y Avg
16.43
Market Cap
$419.62M
Current Ratio
6.74
TTM Avg
3.59
3Y Avg
4.96
5Y Avg
4.92
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Editas Medicine, Inc. (EDIT) | $434.82M | 3.19 | 3.12 | 3.84 | 6.36 |
| Assembly Biosciences, Inc. (ASMB)vs › | $437.61M | 13.99 | 3.82 | 4.25 | 5.96 |
| Capricor Therapeutics, Inc. (CAPR)vs › | $440.53M | 7.35 | 8.39 | 5.06 | 6.73 |
| NeoGenomics, Inc. (NEO)vs › | $427.95M | 3.60 | 3.12 | 4.79 | 5.52 |
| NeuroPace, Inc. (NPCE)vs › | $444.52M | 4.94 | 5.33 | 6.32 | 7.54 |
| Ovid Therapeutics Inc. (OVID)vs › | $447.00M | 12.39 | 8.12 | 11.14 | 10.14 |
| ARS Pharmaceuticals, Inc. (SPRY)vs › | $422.13M | 3.48 | 10.77 | 42.35 | 30.00 |
| DiaMedica Therapeutics Inc. (DMAC)vs › | $448.85M | 6.72 | 10.04 | 13.74 | 16.43 |
| Senseonics Holdings, Inc. (SENS)vs › | $419.62M | 6.74 | 3.59 | 4.96 | 4.92 |
| Rezolute, Inc. (RZLT)vs › | $418.02M | 9.44 | 11.90 | 14.34 | 23.42 |
Current Ratio
3.19
Quick Ratio
3.19
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 3.19 |
| 2026-03-31 | 3.22 |
| 2025-12-31 | 3.54 |
| 2025-09-30 | 2.86 |
| 2025-06-30 | 2.77 |
| 2025-03-31 | 3.08 |
| 2024-12-31 | 3.75 |
| 2024-09-30 | 3.75 |
| 2024-06-30 | 3.85 |
| 2024-03-31 | 4.60 |
| 2023-12-31 | 5.39 |
| 2023-09-30 | 6.12 |
| 2023-06-30 | 8.09 |
| 2023-03-31 | 5.68 |
| 2022-12-31 | 5.94 |
| 2022-09-30 | 10.09 |
| 2022-06-30 | 12.67 |
| 2022-03-31 | 13.62 |
| 2021-12-31 | 10.82 |
| 2021-09-30 | 11.15 |
| 2021-06-30 | 9.34 |
| 2021-03-31 | 9.88 |
| 2020-12-31 | 7.20 |
| 2020-09-30 | 9.25 |
| 2020-06-30 | 8.95 |
| 2020-03-31 | 6.17 |
| 2019-12-31 | 7.74 |
| 2019-09-30 | 5.08 |
| 2019-06-30 | 4.45 |
| 2019-03-31 | 8.46 |
| 2018-12-31 | 10.44 |
| 2018-09-30 | 13.13 |
| 2018-06-30 | 14.50 |
| 2018-03-31 | 11.71 |
| 2017-12-31 | 9.05 |
| 2017-09-30 | 10.12 |
| 2017-06-30 | 6.73 |
| 2017-03-31 | 7.04 |
| 2016-12-31 | 5.66 |
| 2016-09-30 | 14.79 |
| 2016-06-30 | 16.12 |
| 2016-03-31 | 22.71 |
| 2015-12-31 | 20.94 |
| 2015-09-30 | 28.66 |
| 2015-06-30 | 5.07 |
| 2015-03-31 | 0.00 |
| 2014-12-31 | 1.74 |
| 2014-09-30 | 0.00 |
| 2014-06-30 | 0.00 |
| 2014-03-31 | 0.00 |
